Navigating the Chinese biomarket with confidence
Welcome to Biomarket Advisory.
We empower Swiss companies to successfully enter and thrive in the dynamic Chinese biomarket.
Discover our expert consulting services tailored to your unique needs.
Ready to unlock the Chinese biopharmaceutical market
but unsure where to start?
Your partner in China biomarket insights
Biomarket Advisory (BA) provides unparalleled expertise for our clients, including Pharma, Biotech, and VC/PE, seeking opportunities.
We offer a specialized range of consulting services designed to address your needs and solve your key concerns.
We deliver strategic insights and practical solutions to ensure your journey into this complex market is smooth and successful.
Our services
We offer specialized consulting services focused on oncology, neurodegenerative, and cardiovascular diseases.
Our approach is centered on understanding your specific needs and providing effective and practical solutions.
Early Asset Strategy
Guiding early-stage asset positioning and decision-making, from market and competitive landscape to KOL insights and clinical development strategy.
Local Digital Marketing
Navigate platforms like WeChat, Xiaohongshu(Rednote) or other Chinese e-commerce to effectively reach your target customers.
Scientific & Medical Analysis
Integrating disease science, unmet medical needs, and publication strategy to generate evidence-based insights and guide strategic decisions in the field.
Tailored solutions
From small and medium-sized enterprises to large global corporations, we tailor our solutions to meet your unique needs.
BA
Based in Switzerland, Biomarket Advisory (BA) was founded to bridge the gap between Swiss/international innovation and the vast opportunities in China. We are committed to providing clear, actionable, and culturally sensitive advice to ensure your success.
Get in touch
By submitting this form, you agree to our Terms & Conditions, Privacy Policy, and Medical Disclaimer.
Create Your Own Website With Webador